Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;33(3):167-73.
doi: 10.1159/000316700. Epub 2010 Jun 23.

Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney

Affiliations

Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney

Danita Eatman et al. Kidney Blood Press Res. 2010.

Abstract

Background/aim: It is well accepted that high dietary salt intake accelerates both hypertension and target organ damage. We have previously shown that eplerenone attenuates sustained elevated systolic blood pressure in Dahl salt-sensitive (SS) rats. In the present study, we investigated the role of eplerenone on vascular endothelial growth factor (VEGF) expression because we suspected that eplerenone treatment may trigger a unique mechanism that relies on the downregulation of VEGF.

Methods: Dahl SS rats were fed a high salt (8% NaCl) diet for 3 weeks and then switched to normal salt (0.3% NaCl) diet with or without treatment with eplerenone (100 mg/kg/day), enalapril (30 mg/kg/day) and their combination for an additional 3 weeks.

Results: In addition to reducing blood pressure, eplerenone inhibited glomeruli sclerosis and suppressed the expression of VEGF and endothelial nitric oxide synthase mRNA as well as protein levels.

Conclusions: Based on these findings, we suggest that in part, VEGF stimulation of endothelial nitric oxide synthase plays a significant role in the eplerenone-induced reversal of the renal and vascular damage caused by high dietary salt intake.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Glomeruli sclerosis in Dahl SS rats. Photomicrographs (orig. magnif. × 200) of the histopathology of HE-stained kidney sections from SS rats fed 3 weeks high salt diet followed by 3 weeks low salt diet (control) with or without drug treatment with enalapril treatment (ENA), eplerenone (EPL), or their combination (ENA + EPL). Sections shown are typical of the 4 rats/group. a Control sections showing severe focal glomerulosclerosis (arrow highlights glomerulosclerosis). b Kidney section from an ENA-treated rat showing mild focal glomerulosclerosis. c Section from an EPL-treated rat showing no histopathologic changes.
Fig. 2
Fig. 2
Renal VEGF and eNOS protein expression in Dahl SS rats fed a low or high salt diet with eplerenone (100 mg/kg/day). Representative Western blot of a VEGF, b eNOS, and c relative VEGF and eNOS content (arbitrary units). Densitometry units were normalized to actin. Data represent the mean ± SEM of three replicates. ∗ p < 0.05 when compared to LS; ∗∗ p < 0.05 when compared to LS/EPL; # p < 0.05 when compared to HS.

Similar articles

Cited by

References

    1. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension. 2004;43:142–146. - PubMed
    1. Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension. Clin Exp Hypertens. 2005;4:355–367. - PubMed
    1. Cachofeiro V, Miana M, de Las Heras N, Martin-Fernandez B, Ballesteros S, Fernandez-Tresguerres J, Lahera V. Aldosterone and the vascular system. J Steroid Biochem Mol Biol. 2008;109:331–335. - PubMed
    1. Cortinovis M, Perico N, Cattaneo D, Remuzzi G. Aldosterone and progression of kidney disease. Ther Adv Cardiovasc Dis. 2009;3:133. - PubMed
    1. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension. 2002;39:614–618. - PubMed

Publication types

MeSH terms

Substances